Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Inventory Average (2016 - 2023)

Lexaria Bioscience's Inventory Average history spans 8 years, with the latest figure at $8762.0 for Q1 2023.

  • For Q1 2023, Inventory Average fell 70.24% year-over-year to $8762.0; the TTM value through Feb 2023 reached $8762.0, down 70.24%, while the annual FY2022 figure was $34033.0, 53.54% down from the prior year.
  • Inventory Average for Q1 2023 was $8762.0 at Lexaria Bioscience, down from $24177.0 in the prior quarter.
  • Across five years, Inventory Average topped out at $157835.5 in Q3 2019 and bottomed at $8762.0 in Q1 2023.
  • The 5-year median for Inventory Average is $65607.5 (2021), against an average of $79624.1.
  • The largest annual shift saw Inventory Average soared 113.16% in 2019 before it tumbled 70.24% in 2023.
  • A 5-year view of Inventory Average shows it stood at $130476.0 in 2019, then crashed by 57.54% to $55402.0 in 2020, then crashed by 48.91% to $28307.0 in 2021, then decreased by 14.59% to $24177.0 in 2022, then tumbled by 63.76% to $8762.0 in 2023.
  • Per Business Quant, the three most recent readings for LEXX's Inventory Average are $8762.0 (Q1 2023), $24177.0 (Q4 2022), and $39300.5 (Q3 2022).